Bellicum Pharmaceuticals Provides Operational Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2017

World News: . []

HOUSTON March 13 2018 GLOBE NEWSWIRE -- Bellicum Pharmaceuticals IncNASDAQBLCM a leader in developing novel controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today reported financial results for t he four...

More news and information about Bellicum Pharmaceuticals, Inc.

Published By:

Globe Newswire: 20:01 GMT Tuesday 13th March 2018

Published: .

Search for other references to "bellicum" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us